Ou Hai

Title: An Insight into the Innovations of Inventor Ou Hai

Introduction: Ou Hai, an accomplished inventor based in Jiangsu, China, has made significant contributions to the field of pharmaceuticals. With a remarkable focus on the development of innovative compounds, his research has led to meaningful advancements in cancer treatment.

Latest Patents: Ou Hai holds a patent for a crystal form of monomethanesulfonate of a deuterated 3-(4,5-substituted aminopyrimidine)phenyl compound. This invention details a highly stable crystal form that can be utilized in the treatment or prevention of diseases through epidermal growth factor receptors (EGFRs) in certain mutation forms. His research indicates that the compound effectively inhibits the growth of various tumor cells and has a significant inhibitory effect on other proteases within the EGFR and Her families, making it a valuable candidate for antitumor drug formulation.

Career Highlights: Currently, Ou Hai is affiliated with Nanjing Chuangte Pharmaceutical Technology Co., Ltd., where he continues to focus on developing groundbreaking pharmaceutical technologies. His role within the company emphasizes collaboration and innovation, which has been pivotal in enhancing the company's research capabilities.

Collaborations: Throughout his career, Ou Hai has worked alongside notable colleagues such as Yongqiang Zhu and Yang Yang. Their collaboration fosters a rich environment for innovation, facilitating the exchange of ideas that drive their research forward.

Conclusion: Ou Hai's dedication to pharmaceutical innovation, particularly in developing new treatments for cancer, highlights the importance of research and collaboration in the field. His patent serves as a testament to his contributions, showcasing how inventions can lead to transformative healthcare solutions.